Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
Operating Expenses | 1,959 | 2,891 | 2,484 | 0 | 5,999 |
Operating Income | -1,959 | -2,891 | -2,484 | N/A | -5,999 |
Other Income | 1,268 | -21 | -754 | 0 | 159 |
Pre-tax Income | -691 | -2,913 | -3,238 | 0 | -5,840 |
Net Income Continuous | -691 | -2,913 | -3,238 | N/A | -5,840 |
Net Income | $-691 | $-2,913 | $-3,238 | $N/A | $-5,840 |
EPS Basic Total Ops | -3,029.78 | -12,805.12 | -14,234.27 | N/A | -25,810.32 |
EPS Basic Continuous Ops | -3,040.24 | -12,813.90 | -14,243.54 | N/A | -25,804.70 |
EPS Diluted Total Ops | -3,029.78 | -12,805.12 | -14,234.27 | N/A | -25,810.32 |
EPS Diluted Continuous Ops | -3,040.24 | -12,813.90 | -14,243.54 | N/A | -25,804.70 |
EBITDA(a) | $-1,953 | $-2,886 | $-2,479 | $N/A | $-5,999 |